Joint Accelerator Launched by Skolkovo and AstraZeneca

06 May 2019
RIA Novosti

The Skolkovo Foundation and AstraZeneca launched Startup Challenge 2019, a new joint accelerator for projects in oncology, cardiovascular, metabolism, renal, respiratory, and other diseases, the foundation said.

224.0 mln
Jobs: 200
Kaluga region

Investor profile

AstraZeneca PLC

United Kingdom

Company's website:

T: +44 2076048000

Public company (NYSE: AZN)

Contact: Pascal Soriot, Director General

AstraZeneca PLC is an Anglo-Swedish pharmaceutical company incorporated in the UK. As of 2014, it is the tenth largest company in the world by sales of prescription drugs. AstraZeneca's product portfolio includes medication for various therapeutic areas, such as cardiology, pulmonology, oncology, neurology, gastroenterology, psychiatry and infectious diseases. The company was formed in 1999 through the merger of the Swedish and British Astra AB Zeneca Group (formed as a result of separating the pharmaceutical business of Imperial Chemical Industries in 1993).